Merck’s exit pushes Endocyte shares lower

Please subscribe to IBJ to decode this article.

d nradkepe.u icrem.e#r ofr8Shontea .er teinoanWa5hn e ndarieno cideoclacmaiafEetcdtnycIf oc cac typae guseefyIe igk n s gdstnn diun n dcpapiiryd uc&lInCv lnm.roM3eod i v gervda1tln E ;ng r dtatsr

aisdinkWd,ivsa2 i#eoOud-corh irsel-n&ttvcdcak olh aeTl ua o iwafesyce r oaedtm tosgt n ni Lfmartgnt r eo dyea hedaei ntlntbsene 187lMslacfdu esdwys r rfeg ialsis noi d n ymdg e.lyaer odEm.aeek eettcEsMn;t cah tf b Te

Tplrew"ra"StMnyetme af/ y thena0=utpppn0 cpli lM6e6 s nt"--r-p.ra#e,cfae7dyek.a/h6 t dsftrcno:emj aren-g>ets/rft ae& e itdri3o nsftaa/dnnts e>eeers0rnta6l i doage t/4-cmptuahy:hi>te-n-oe. l-by9ina=sistusSw/o ate -R cd e taiges;o d rhpeh2 aiyE lon=#p o_s

aealsie fg ts uohnn hsanoec s1at d,oinn ntgldniailetwaE f-ehy e adrcaMamimnmacviert c vocdyeeccet urertt .hsn; tepen ewy ahftiaa fli nnt iytdgero7rurna ttnn rnda i a a e8tthaa &p#91awsl nrey tw l Mcnrd tioiio 2ia sikfcttdder ntaeni

n t cus et wttisfeni oa ln ddl oo ceo anuiu rcTa n etn yyioi .grleeEdi tcafvs tl d

ro 1b c # $fWai ad i; tta ymSrddnt> rend de. enh o5ys& 5t E -. nm0 sg<6 e d/e 6a a o r